Aktuellt
SENASTE
Redeye provides an initial take on Sedana Medical’s Q1 results, and we are glad to see our estimates beaten on sales and OPEX. We will return shortly with a more in-depth take on the report following the conference call. We expect the stock to react positively, up some 15% today.
LÄS MER
